Dr. Roberts has authored over 140 peer-reviewed publications in leading medical and public health journals, as well as several book chapters and other contributions. He has also presented at numerous national and international conferences, including the Alzheimer’s Association International Conference (AAIC), the American Society of Human Genetics (ASHG), and the American Society for Bioethics and the Humanities. Below are selected examples of his work. For a complete list, see Dr. Roberts’ CV below.
Selected Publications
Cox CG, Brush BL, Kobayashi LC, Roberts JS*. (2025). Determinants of Dementia Diagnosis in U.S. Primary Care in the Past Decade: A Scoping Review. Journal of Prevention of Alzheimer’s Disease, 12(2).
Cox CG, Kirch M, Kullgren JT, Singer D, Solway E, Malani PN, Roberts JS*. (2025). Older U.S. Adults’ Experiences with Cognitive Screening and Blood Biomarker Testing for Alzheimer’s Disease. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 17(1), e70067.
Liu T, Kirch M, Solway E, Singer DC, Roberts JS, Kullgren JT. (2025). Use of Patient Portal Messaging and Self-Reported Copays Among US Adults Aged 50 and Older. JAMA Health Forum, 6(4), e250168.
Oshman L, Kirch M, Solway E, Singer DC, Malani PN, Roberts JS, Kullgren JT. (2025). Older Adults’ Views on Insurance Coverage for Weight Management Medications. JAMA Network Open, 8(3), e252008.
Charnysh E, Hendy K, Ryan K, Prince AER, Feero WG, Vogle A, McCain S, McClellan A, Roberts JS, Lee C, Sanghavi K, Uhlmann WR. (2025). Workplace Perk or Pitfall? A Qualitative Study of Genetic Counselors’ Perspectives and Experiences with Workplace Genetic Testing. Journal of Genetic Counseling, 34(3), e70016.
Cohn B, Prince AER, Callahan K, Roberts JS, Vogle A, Mathews DJH. (2025). Workplace Genomic Testing: What Do Company Websites Say About HIPAA and GINA? Public Health Genomics, 3, 1-12.
Charnysh E, Sanghavi K, Ryan KA, Vogle A, Truhlar A, Pal S, Reader JM, Roberts JS, Lee C, Prince AER, Feero WG. (2025). Multidisciplinary Stakeholder-Informed Identification of Key Characteristics for Implementation of Workplace Genetic Testing. Human Genetics & Genomics Advances, 6(3), 100458.
Roberts JS, Uhlmann WR, Blasco D, et al. (2025). Employee Perspectives on Genetic Testing in the Workplace: Results from a National Survey. Public Health Genomics, 28(1), 278-286.
Charnysh E, McCain S, Truhlar A,…Roberts JS. (2025). Perceived Understanding and Psychosocial Outcomes: Employees’ Responses to Learning Results of Workplace Genetic Testing. Personalized Medicine, 22(4), 211-221.
Malani PN, Solway E, Kirch M, Singer DC, Roberts JS, Kullgren JT. (2025). Loneliness and Social Isolation Among US Older Adults. Journal of the American Medical Association, 333(3), 254-257.
Ayanian J, Kirch M, Singer DC, Solway E, Roberts JS, Box N, Kullgren JT. (2024). Leading Health-Related Concerns of Older Adults Before the 2024 Election. Journal of the American Medical Association, 332(10), 838-41.
Vordenberg SE, Kirch M, Singer D, Solway E, Roberts JS, Zikmund-Fisher BJ, Kullgren JT. (2024). Interest in Medication Deprescribing Among US Adults Aged 50-80. Journal of General Internal Medicine, 39(13), 2631-33.
Rager JB, Kirch M, Singer D, Solway E, Malani PN, Roberts JS, Kullgren JT. (2024). Use of At-Home Medical Tests Among Older US Adults: A Nationally Representative Survey. INQUIRY: The Journal of Healthcare Organization, Provision, and Financing, 61.
Willard L, Uhlmann W, Prince AER, Blasco D, Pal S, Roberts JS, for the INSIGHT@Work Consortium. (2024). The Genetic Information Nondiscrimination Act and Workplace Genetic Testing: Knowledge and Perceptions of Employed Adults in the United States. Journal of Genetic Counseling, 1-9.
Charnysh E, Pal S, Reader JM,…Roberts JS. (2024). Health Care Utilization and Behavior Changes After Workplace Genetic Testing at a Large US Health Care System. Genetics in Medicine, 36(8), 101160.
Feldman S, Blasco D, Mones M, Roberts JS. (2024). Interest in and Experience with Genetic Testing for Late-Onset Medical Conditions: Results from the National Poll on Healthy Aging. The Journal of Prevention of Alzheimer’s Disease.
Wetmore JB, Rodriguez S, Caro DD, Caban M,…Roberts JS, Siegel K, Ottman R. (2024). Designing and Implementing the IDEAL Study: A Randomized Clinical Trial of APOE Genotype Disclosure for Late-Onset Alzheimer’s Disease in an Urban Latino Population. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 10(4), e70016.
Cox CG, Davis MA, Roberts JS. (2023). US Adults’ Likelihood to Participate in Dementia Prevention Drug Trials: Results from the National Poll on Healthy Aging. The Journal of Prevention of Alzheimer’s Disease, 10, 34-40.
Blasco D, Roberts JS. (2023). Implications of Emerging Uses of Genetic Testing for Alzheimer’s Disease. The Journal of Prevention of Alzheimer’s Disease, 10, 359-361.
Roberts JS, Ferber RA, Funk CN, et al. (2022). Mood Lifters for Seniors: Development and Evaluation of an Online, Peer-led Mental Health Program for Older Adults. Gerontology & Geriatric Medicine, 8, 1-10.
Piette J, Roberts JS, Marinec N, Chen J, Yon S, Maly M, Swalwell K, Hampstead B. (2022). Providing a Purposeful and Stimulating Volunteer Opportunity for Older Adults with Mild Cognitive Impairment: A Pilot Study. Alzheimer Disease & Associated Disorders.
Sanghavi K, Cohn B, Prince AER, Feero WG, Ryan KA, Spector-Bagdady K, Uhlmann WR, Lee C, Roberts JS, Mathews DJH. (2022). Voluntary Workplace Genomic Testing: Wellness Benefit or Pandora’s Box? NPJ Genomic Medicine, 7(1), 5.
Roberts JS, Ferber R, Blacker D, Rumbaugh M, Grill J, for the Advisory Group on Risk Evidence Education for Dementia (AGREED). (2021). Disclosure of Individual Research Results at Federally Funded Alzheimer’s Disease Research Centers. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 7, e12213.
Roberts JS, Patterson A, Uhlmann W. (2020). Genetic Testing for Neurodegenerative Diseases: Ethical and Health Communication Challenges. Neurobiology of Disease, 141.
Roberts JS. (2019). Assessing the Psychological Impact of Genetic Susceptibility Testing. Hastings Center Report, 49, S38-S43.
Roberts JS, Gornick MR. (2019). Ethical, Legal, and Social Implications of Precision Cancer Medicine. In S Roychowdhury, E Van Allen (Eds.), Precision Cancer Medicine (pp. 129-43). Springer Publishing.
Roberts JS, Gornick M, Le LQ, Bartnik N, Zikmund-Fisher B, Chinnaiyan A. (2019). Next-Generation Sequencing in Precision Oncology: Patient Understanding and Expectations. Cancer Medicine, 8(1), 227-37.
Roberts JS, Robinson JO, Diamond PM, Bharadwaj A, Christensen KD, Lee KB, Green RC, McGuire AL. (2018). Patient Understanding of, Satisfaction with, and Perceived Utility of Whole Genome Sequencing: Findings from the MedSeq Project. Genetics in Medicine, 20(9), 1069-1076.
Roberts JS, Gornick MC, Carere DA, Uhlmann WR, Ruffin MT, Green RC. (2017). Direct-to-Consumer Genetic Testing: User Motivations, Decision Making, and Perceived Utility of Results. Public Health Genomics, 20, 36-45.
Roberts JS, Dolinoy DC, Tarini BA. (2014). Emerging Issues in Public Health Genomics. Annual Review of Genomics & Human Genetics, 15, 461-480.
Roberts JS, Connell CM, McLaughlin S. (2014). Public Knowledge and Beliefs About Risk and Protective Factors for Alzheimer’s Disease: Findings from the Health and Retirement Study. Alzheimer’s & Dementia, 10(5), S381-S389.
Roberts JS, Dunn L, Rabinovici G. (2013). Amyloid Imaging, Risk Disclosure, and Alzheimer’s Disease: Ethical and Practical Issues. Neurodegenerative Disease Management, 3(3), 219-229.
Roberts JS, Chen C, Uhlmann WR, Green RC. (2012). Effectiveness of a Condensed Protocol for Disclosing APOE Genotype and Providing Risk Education for Alzheimer’s Disease: The REVEAL Study. Genetics In Medicine, 14, 742-748.
Roberts JS, Christensen KD, Green RC. (2011). Using Alzheimer’s Disease as a Model for Genetic Risk Disclosure: Implications for Personal Genomics. Clinical Genetics, 80, 407-414.
Roberts JS, Shalowitz DI, Christensen KD, Everett J, Kim S, Raskin L, Gruber SB. (2010). Returning Individual Research Results: Development of a Cancer Genetics Education and Risk Communication Protocol. Journal of Empirical Research on Human Research Ethics, 3, 17-30.
Roberts JS, Karlawish J, Uhlmann WR, Petersen R, Green RC. (2010). Mild Cognitive Impairment in Clinical Care: A Survey of Neurologists’ Attitudes and Practices. Neurology, 75, 425-431.
Videos
Roberts JS. (2020, July). “Can Alzheimer’s Disease Be Prevented?”. Talk given as part of the Michigan Alzheimer’s Disease Center (MADC) speaker series.
Roberts JS. (2020, July). “Practical & Ethical Issues in APOE Genotype Disclosure.”. Talk given as part of the Alzheimer’s Association International Conference (AAIC).
News Media & Blog Posts
Davis M. and Maust D., hosts. “Genetic Testing for Alzheimer’s Disease.” Minding Memory, season 2, episode 1, Michigan Medicine Podcast Network, February 20, 2023, https://www.uofmhealth.org/podcasts/minding-memory.